Rhoen Klinikum AG (ETR:RHK) has been given a €25.00 ($29.41) price target by investment analysts at Commerzbank Ag in a report issued on Tuesday, July 25th. The firm currently has a “neutral” rating on the stock.
Other equities analysts also recently issued research reports about the company. Baader Bank set a €24.00 ($28.24) price objective on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Thursday, June 8th. DZ Bank AG reaffirmed a “sell” rating on shares of Rhoen Klinikum AG in a research report on Monday, May 29th. Three equities research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of €24.06 ($28.31).
Rhoen Klinikum AG (ETR:RHK) traded up 0.379% during mid-day trading on Tuesday, reaching €27.517. 150 shares of the company traded hands. The firm has a market capitalization of €1.84 billion and a P/E ratio of 429.953. Rhoen Klinikum AG has a 12-month low of €22.91 and a 12-month high of €27.52. The company’s 50 day moving average price is €26.17 and its 200 day moving average price is €25.89.
Rhoen Klinikum AG Company Profile
Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.